Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, has appointed Norm Stoffregen as SVP, site head, and head of biologics manufacturing at the company’s new $50 million manufacturing facility in Hopewell, near Princeton, New Jersey.   As well as taking responsibility for Enzene’s global biologics business, Stoffregen will lead the final stages of work to commission the 54,000-square-foot facility. He will then lead ongoing operation...